SCHEMBL21784827

SCHEMBL21784827

c1ccc(-c2nc(-c3ccc(-c4ccc5oc6cc7c(cc6c5c4)oc4ccccc47)cc3)nc(-c3cccc4c3sc3ccccc34)n2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 1/20 0.41
PRKDC P78527 6/20 0.39
LIMK1 P53667 2/20 0.37
PLA2G2A P14555 3/20 0.36
PLA2G4A P47712 3/20 0.36
PLA2G10 O15496 1/20 0.35
PIK3CD O00329 2/20 0.34
PIK3CB P42338 2/20 0.34
PIM3 Q86V86 2/20 0.34
PIM1 P11309 1/20 0.33
CSNK2A2 P19784 1/20 0.33
CSNK2B P67870 1/20 0.33
PIM2 Q9P1W9 1/20 0.33
CHEK2 O96017 1/20 0.33
BRD4 O60885 1/20 0.33
PIK3CA P42336 1/20 0.33
MTOR P42345 1/20 0.33
PIK3CG P48736 1/20 0.33
KCNH2 Q12809 1/20 0.33
BRDT Q58F21 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21784857 1.00 ALOX5 (0.41) ALOX5PRKDCLIMK1PLA2G2APLA2G4A
SCHEMBL24318042 0.99 ALOX5 (0.40) ALOX5PRKDCLIMK1PLA2G2APLA2G4A
SCHEMBL21784866 0.98 ALOX5 (0.41) ALOX5PRKDCLIMK1PLA2G2APLA2G4A
SCHEMBL24318044 0.98 ALOX5 (0.41) ALOX5PRKDCLIMK1PLA2G2APLA2G4A
SCHEMBL21784883 0.98 ALOX5 (0.43) ALOX5PRKDCLIMK1PLA2G2APLA2G4A
SCHEMBL21784867 0.97 PRKDC (0.41) ALOX5PRKDCLIMK1PLA2G2APLA2G4A
SCHEMBL24318008 0.97 ALOX5 (0.40) ALOX5PRKDCLIMK1PLA2G2APLA2G4A
SCHEMBL26080585 0.97 ALOX5 (0.42) ALOX5PRKDCLIMK1PLA2G2APLA2G4A
SCHEMBL24318012 0.96 ALOX5 (0.40) ALOX5PRKDCLIMK1PLA2G2APLA2G4A
SCHEMBL24264255 0.96 PRKDC (0.43) ALOX5PRKDCLIMK1PLA2G2APLA2G4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220109115-A1 POLYCYCLIC COMPOUND, AND AN ORGANIC ELECTROLUMINESCENCE DEVICE COMPRISING THE POLYCYCLIC COMPOUND IDEMITSU KOSAN CO.,LTD. (JP) 2022-04-07 US disclosed
WO-2020044270-A1 POLYCYCLIC COMPOUND, AND AN ORGANIC ELECTROLUMINESCENCE DEVICE COMPRISING THE POLYCYCLIC COMPOUND IDEMITSU KOSAN CO., LTD. (JP) 2020-03-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220109115-A1 POLYCYCLIC COMPOUND, AND AN ORGANIC ELECTROLUMINESCENCE DEVICE COMPRISING THE POLYCYCLIC COMPOUND ODC1, OTC, PKD1 ALOX5 1698/4885PRKDC 2806/4885LIMK1 1430/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.